Compare GSK plc (GSK) vs iShares MBS ETF (MBB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs iShares MBS ETF — how do they compare? GSK plc trades at $52.8 (market cap $101.34B), while iShares MBS ETF trades at $93.77. The key difference: GSK plc pays a 3.49% dividend while iShares MBS ETF pays none, and GSK plc is trading nearer its 52-week high, iShares MBS ETF nearer its low. Which is the better fit depends on your goals.
| GSK | MBB | |
|---|---|---|
Market Cap | $101.34B | — |
Sector | Health | — |
52-Week High | $61.18 | $96.91 |
52-Week Low | $36.20 | $92.62 |
Enterprise Value | $121.95B | — |
Dividend Yield | 3.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK's stock trades at $51.25, down 1.99% on the day, with a bearish technical signal from moving averages. Fundamentally, the company shows strong profitability with a 17.78% net margin and 36.42% ROE, supported by a consistent earnings beat history. Recent positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline progress. Valuation appears reasonable with a P/E of 13.71 and EV/EBITDA of 9.16.
The outlook balances a solid core business and promising oncology pipeline against a mixed analyst consensus and near-term cash flow pressures. Key opportunities lie in execution of new drug launches and the upcoming CEO strategy update, while risks include clinical trial setbacks, competitive pressures, and integration of potential acquisitions like Nuvalent.
The iShares MBS ETF (MBB) trades at $93.665, showing minimal daily movement with a slight decline of 0.01%. Technical indicators present a bearish bias, with moving averages signaling selling pressure and oscillators in neutral territory. Recent institutional activity shows mixed positioning, with some firms increasing stakes while others reduced holdings. The ETF maintains a consistent dividend distribution schedule, with recent payments around $0.33 per share.
As a mortgage-backed securities ETF, MBB offers exposure to the U.S. housing debt market with monthly dividend distributions. The fund faces interest rate sensitivity and prepayment risks inherent to MBS investments. While providing diversification within real estate fixed income, investors should monitor Federal Reserve policy and housing market trends that directly impact underlying security performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About iShares MBS ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index and TBAs that have economic characteristics that are substantially identical to the economic characteristics of the component securities of the index, and the fund will invest at least 90% of its assets in fixed income securities included in the underlying index that advisor believes will help the fund track the index.
Read more on MBB →
